Alnylam Pharma(MX:ALNY)
MX$2,950.000.00 (0.00%)
MX:ALNY
Alnylam Pharma earnings date
MX$2,950.00
At close:0.00 (0.00%)
Alnylam Pharma (ALNY) Q1 2026 Earnings Report
0 Followers
MX:ALNY Q1 2026 EPS Results
- Actual EPS
- MXN 28.57
- Consensus EPS
- MXN 16.50
- Beat/Miss
- Beat by +MXN 12.07
- One Year Ago EPS
- -MXN 8.33
MX:ALNY Q1 2026 Revenue Results
- Actual Revenue
- MXN 22.09B
- Expected Revenue
- MXN 21.11B
- Beat/Miss
- Beat by +MXN 977.61M
- YoY Revenue Growth
- +96.43%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 04/30/2026
- Time
- Before Open
- Conference Call
- Thursday, April 30, 2026
MX:ALNY Upcoming Earnings
Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
MX:ALNY Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ALNY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 32.60- | 15.52 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 31.41297.47 | 34.82 | 754.35% (+262.65) | |
| Jul 30, 2026 | 2026 (Q2) | 30.8422.90 | -9.65 | 337.25% (+32.55) | |
| Apr 30, 2026 | 2026 (Q1) | 16.5028.57 | -8.33 | 443.18% (+36.90) | |
| Feb 12, 2026 | 2025 (Q4) | 21.7615.52 | -12.3 | 226.15% (+27.82) | |
| Oct 30, 2025 | 2025 (Q3) | 10.6234.82 | -16.46 | 311.49% (+51.28) | |
| Jul 31, 2025 | 2025 (Q2) | -10.29-9.65 | -2.46 | -292.31% (-7.19) | |
| May 01, 2025 | 2025 (Q1) | -16.84-8.33 | -9.84 | 15.38% (+1.51) | |
| Feb 13, 2025 | 2024 (Q4) | -11.20-12.30 | -20.82 | 40.91% (+8.52) | |
| Oct 31, 2024 | 2024 (Q3) | -17.35-16.46 | 21.76 | -175.65% (-38.22) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


